1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole

Product Name1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole
CAS16502-01-5
MFC11H12N2
MW172.23
EINECS
MOL File16502-01-5.mol

Chemical Properties

Melting point	206-208 °C(lit.)
Boiling point	351.6±32.0 °C(Predicted)
Density	1.189±0.06 g/cm3(Predicted)
storage temp.	Keep in dark place,Sealed in dry,Room Temperature
solubility	10mg/mL in 1N Ammonium Hydroxide in Methanol, DMSO
form	Powder or Crystals
pka	17.78±0.20(Predicted)
color	White to slightly yellow
InChI	InChI=1S/C11H12N2/c1-2-4-10-8(3-1)9-5-6-12-7-11(9)13-10/h1-4,12-13H,5-7H2
InChIKey	CFTOTSJVQRFXOF-UHFFFAOYSA-N
SMILES	N1C2=C(C=CC=C2)C2CCNCC1=2
LogP	1.816 (est)
CAS DataBase Reference	16502-01-5(CAS DataBase Reference)

Safety Information

Hazard Codes	Xi
Risk Statements	36/37/38
Safety Statements	26-36
WGK Germany	3
HazardClass	IRRITANT
HS Code	29339900
Storage Class	11 - Combustible Solids
Hazard Classifications	Eye Irrit. 2 Skin Irrit. 2 STOT SE 3

MSDS

Provider	Language
SigmaAldrich	English

Usage And Synthesis

Chemical Properties

Tan Solid

Uses

1,2,3,4-Tetrahydro-β-carboline is a mitotic kinesin inhibitor as novel anti-cancer agent. It is used in the study of neurodegenerative diseases.

Application

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole was employed in alkaloid synthesis and in studies on neurodegenerative diseases.
Reactant for synthesis of the indolyl-β-carboline alkaloid eudistomin U via IBX mediated room temperature oxidative aromatization
Reactant for preparation of neuroprotective HDAC6 inhibitors
Reactant for preparation of aminofuranopyrimidines as EGFR and Aurora A kinase inhibitors
Reactant for preparation of inhibitors of CDK4
Reactant for preparation of tetrahydrocarboline derivatives of as human 5-HT5A receptor ligands
Reactant for preparation of 5-(diaminomethyl)-2,4-aminopyrimidines as dihydrofolate reductase inhibitors and antibacterial agents

Definition

ChEBI: 2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole is a member of beta-carbolines.

General Description

Ozonolysis of the enamine bond of 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indole derivatives was studied.

Synthesis

50-00-0

61-54-1

1,2,3,4-TETRAHYDRO-9H-PYRIDO[3,4-B]INDOLE

16502-01-5

1.5 g of tryptamine was dissolved in a mixed acetic acid/methanol solvent (AcOH/MeOH = 10:1, v/v) and 345 mg of paraformaldehyde was slowly added. The reaction mixture was stirred at 80 °C for 30 min. After completion of the reaction, the progress of the reaction was monitored by TLC. The reaction system was slowly poured into dilute aqueous ammonia solution (NH4OH/H2O = 1:1, v/v, 80 ml) and the pH was adjusted to 10. The organic phases were combined by extracting three times with a solvent mixture of dichloromethane/methanol (CH2Cl2/MeOH = 10:1, v/v). The organic phase was dried with anhydrous sodium sulfate, filtered and concentrated. The crude product was purified by silica gel column chromatography with dichloromethane/methanol (CH2Cl2/MeOH = 10:1, v/v) as eluent to give 1.6 g of Intermediate A in 98% yield. The product was a light yellow solid, stable at room temperature.

in vivo

Tetrahydro-β-carboline (20 μg; i.c.v.) increases the serotonin levels in the same part of the brain in rats^[1].

Animal Model:	180-200g female Sprague-Dawley rats^[1]
Dosage:	20 μg
Administration:	Intraventricular injection
Result:	Increased of serotonin levels in the same part of the brain whereas the monoamine oxidase activity was not altered.

IC 50

serotonin: 6.1 μM (Ki)

References

[1] CHRISTIAN O ALBERTO Michiru H Robert B Trask. Dopamine acts as a partial agonist for α2A adrenoceptor in melanin-concentrating hormone neurons.[J]. Journal of Neuroscience, 2011, 31 29: 10671-10676. DOI:10.1523/JNEUROSCI.6245-10.2011.
[2] IAIN M. MCDONALD. 2,7-Dioxo-2,3,4,5,6,7-hexahydro-1H-benzo[h][1,4]diazonine as a New Template for the Design of CCK2 Receptor Antagonists[J]. Journal of Medicinal Chemistry, 2000, 43 19: 3518-3529. DOI:10.1021/jm000960w.
[3] Rommelspacher, H., Bade, P., Coper, H., et al. Inhibition of the reuptake of serotonin by tryptoline. Naunyn Schmiedebergs Arch. Pharmacol. 292(1), 93-95 (1976).
[4] Pannier, L., and Rommelspacher, H. Actions of tetrahydronorharmane (tetrahydro-β-carboline) on 5-hydroxytryptamine and dopamine mediated mechanisms. Neuropharmacology 20(1), 1-8 (1981).
[5] Rommelspacher, H., Kauffmann, H., Cohnitz, C.H., et al. Pharmacological properties of tetrahydronorharmane (tryptoline). Naunyn Schmiedebergs Arch. Pharmacol. 298(2), 83-91 (1977).

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole

Chemical Properties

Safety Information

MSDS

Usage And Synthesis

Preparation Products And Raw materials

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole Supplier

1,2,3,4-Tetrahydro-9H-pyrido[3,4-b]indole manufacturers

Related Product Information